Tursi, A. and Tiano, M. (2021) “SARS-COV-2 infection might cause transient cutaneous lesions in IBD patients under treatment with adalimumab”, Journal of Gastrointestinal and Liver Diseases, 30(2), pp. 310-311. doi: 10.15403/jgld-3572.